Diagnosis of venous and arterial thromboembolic events in COVID-19 virus-infected patients

J Thromb Thrombolysis. 2020 Aug;50(2):302-304. doi: 10.1007/s11239-020-02163-y.
No abstract available

MeSH terms

  • Arterial Occlusive Diseases / blood
  • Arterial Occlusive Diseases / diagnosis*
  • Arterial Occlusive Diseases / virology
  • Betacoronavirus / pathogenicity*
  • Biomarkers / blood
  • COVID-19
  • COVID-19 Testing
  • Clinical Laboratory Techniques*
  • Coronavirus Infections / blood
  • Coronavirus Infections / diagnosis*
  • Coronavirus Infections / virology
  • Decision Support Techniques*
  • Disseminated Intravascular Coagulation / blood
  • Disseminated Intravascular Coagulation / diagnosis*
  • Disseminated Intravascular Coagulation / virology
  • Female
  • Fibrin Fibrinogen Degradation Products / analysis
  • Fibrinogen / analysis
  • Host-Pathogen Interactions
  • Humans
  • International Normalized Ratio
  • Male
  • Middle Aged
  • Organ Dysfunction Scores
  • Pandemics
  • Platelet Count
  • Pneumonia, Viral / blood
  • Pneumonia, Viral / diagnosis*
  • Pneumonia, Viral / virology
  • Predictive Value of Tests
  • Prothrombin Time
  • Reproducibility of Results
  • Retrospective Studies
  • SARS-CoV-2
  • Thromboembolism / blood
  • Thromboembolism / diagnosis*
  • Thromboembolism / virology
  • Venous Thrombosis / blood
  • Venous Thrombosis / diagnosis*
  • Venous Thrombosis / virology

Substances

  • Biomarkers
  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D
  • Fibrinogen